Matthew Trendowski

Publications

• PU-H71: An Improvement on Nature's Solutions to Oncogenic Hsp90 Addiction
  Pharmacological Research : the Official Journal of the Italian Pharmacological Society. Jun, 2015  |   Pubmed ID: 26117427
• Targeting the Plasma Membrane of Neoplastic Cells Through Alkylation: a Novel Approach to Cancer Chemotherapy
  Investigational New Drugs. Aug, 2015  |   Pubmed ID: 26095786
• Effects of Alkylation and Immunopotentiation Against Ehrlich Ascites Murine Carcinoma In vivo Using Novel Tetra-O-acetate Haloacetamido Carbohydrate Analogs
  European Journal of Medicinal Chemistry. Jun, 2015  |   Pubmed ID: 26005028
• Preferential Enlargement of Leukemia Cells Using Cytoskeletal-directed Agents and Cell Cycle Growth Control Parameters to Induce Sensitivity to Low Frequency Ultrasound
  Cancer Letters. May, 2015  |   Pubmed ID: 25667120
• The Inherent Metastasis of Leukaemia and Its Exploitation by Sonodynamic Therapy
  Critical Reviews in Oncology/hematology. May, 2015  |   Pubmed ID: 25604499
• Chemotherapy with Cytochalasin Congeners in Vitro and in Vivo Against Murine Models
  Investigational New Drugs. Apr, 2015  |   Pubmed ID: 25563824
• Chemotherapy in Vivo Against M109 Murine Lung Carcinoma with Cytochalasin B by Localized, Systemic, and Liposomal Administration
  Investigational New Drugs. Apr, 2015  |   Pubmed ID: 25560541
• Enlargement and Multinucleation of U937 Leukemia and MCF7 Breast Carcinoma Cells by Antineoplastic Agents to Enhance Sensitivity to Low Frequency Ultrasound and to DNA-directed Anticancer Agents
  Anticancer Research. Jan, 2015  |   Pubmed ID: 25550536
• Using Cytochalasins to Improve Current Chemotherapeutic Approaches
  Anti-cancer Agents in Medicinal Chemistry. 2015  |   Pubmed ID: 25322987
• Tolerated Doses in Zebrafish of Cytochalasins and Jasplakinolide for Comparison with Tolerated Doses in Mice in the Evaluation of Pre-clinical Activity of Microfilament-directed Agents in Tumor Model Systems in Vivo
  In Vivo (Athens, Greece). Nov-Dec, 2014  |   Pubmed ID: 25398795
• Exploiting the Cytoskeletal Filaments of Neoplastic Cells to Potentiate a Novel Therapeutic Approach
  Biochimica Et Biophysica Acta. Dec, 2014  |   Pubmed ID: 25286320
• The Rhetoric of Cancer
  Cancer Causes & Control : CCC. Oct, 2014  |   Pubmed ID: 25011402
• The Real Deal: Using Cytochalasin B in Sonodynamic Therapy to Preferentially Damage Leukemia Cells
  Anticancer Research. May, 2014  |   Pubmed ID: 24778021
• The Promise of Sonodynamic Therapy
  Cancer Metastasis Reviews. Mar, 2014  |   Pubmed ID: 24346159